Literature DB >> 16510153

Role of nitric oxide/cyclic GMP and cyclic AMP in beta3 adrenoceptor-chronotropic response.

Leonor Sterin-Borda1, Gustavo Bernabeo, Sabrina Ganzinelli, Lilian Joensen, Enri Borda.   

Abstract

In this study we determine different signaling pathways involved in beta(3) adrenoceptor (beta(3)-AR) dependent frequency stimulation in isolated rodent atria. Promiscuous coupling between different G-proteins and beta(3)-AR could explain the multiple functional effects of beta(3)-AR stimulation. We examine the mechanisms and functional consequences of dual adenylate cyclase and guanylate cyclase pathways coupling to beta(3)-AR in isolated rodent atria. The beta(3)-AR selective agonists ZD 7114 and ICI 215001 stimulated in a dose-dependent manner the contraction frequency that significantly correlated with cyclic AMP (cAMP) accumulation. Inhibition of adenylate cyclase shifted the chronotropic effect to the right. On the other hand, the ZD 7114 activity on frequency was enhanced by the inhibition of nitric oxide synthase (NOS) and soluble guanylate cyclase. This countervailing negative chronotropic nitric oxide-cyclic GMP (NO-cGMP) significantly correlated with the increase on NOS activity and cGMP accumulation. Current analysis showed a negative cross talk between cAMP chronotropic and NO-cGMP effects by inhibition of phospholipase C (PLC), calcium/calmodulin (CaM), protein kinase C (PKC), NOS isoforms and Gi-protein on the effects of beta(3)-AR stimulation. RT-PCR detected both eNOS and nNOS in isolated rat atria. NOS isoforms performed independently. Only nNOS participated in limiting the effect of beta(3)-AR stimulation. In eNOS-KO (eNOS-/-) mice the chronotropic effect of beta(3)-AR agonists did not differ from wild type (WT) mice atria, but it was increased by the inhibition of nNOS activity. Our results suggest that the increase in frequency by beta(3)-AR activation on isolated rodent atria is associated to a parallel increases in cAMP. The nNOS-cGMP pathway negatively modulates beta(3)-AR activation. Multiple signal transduction pathways between G-protein and beta(3)-AR may protect myocardium from catecholamine-induced cardiotoxic effects.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16510153     DOI: 10.1016/j.yjmcc.2006.01.017

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  6 in total

1.  Mechanisms involved in the regulation of mRNA for M2 muscarinic acetylcholine receptors and endothelial and neuronal NO synthases in rat atria.

Authors:  S Ganzinelli; L Joensen; E Borda; G Bernabeo; L Sterin-Borda
Journal:  Br J Pharmacol       Date:  2007-03-26       Impact factor: 8.739

2.  miR-222 contributes to sex-dimorphic cardiac eNOS expression via ets-1.

Authors:  Alicia M Evangelista; Anne M Deschamps; Delong Liu; Nalini Raghavachari; Elizabeth Murphy
Journal:  Physiol Genomics       Date:  2013-04-30       Impact factor: 3.107

3.  Isoproterenol-induced heart failure in the rat is associated with nitric oxide-dependent functional alterations of cardiac function.

Authors:  Peter Krenek; Jana Kmecova; Dana Kucerova; Zuzana Bajuszova; Peter Musil; Andrea Gazova; Peter Ochodnicky; Jan Klimas; Jan Kyselovic
Journal:  Eur J Heart Fail       Date:  2009-02       Impact factor: 15.534

4.  Activation of inwardly rectifying Kir2.x potassium channels by beta 3-adrenoceptors is mediated via different signaling pathways with a predominant role of PKC for Kir2.1 and of PKA for Kir2.2.

Authors:  Daniel Scherer; Claudia Kiesecker; Martin Kulzer; Myriam Günth; Eberhard P Scholz; Sven Kathöfer; Dierk Thomas; Martin Maurer; Jörg Kreuzer; Alexander Bauer; Hugo A Katus; Christoph A Karle; Edgar Zitron
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-05-30       Impact factor: 3.195

Review 5.  Molecular pathways of oestrogen receptors and β-adrenergic receptors in cardiac cells: Recognition of their similarities, interactions and therapeutic value.

Authors:  J O Machuki; H Y Zhang; S E Harding; H Sun
Journal:  Acta Physiol (Oxf)       Date:  2017-10-30       Impact factor: 6.311

Review 6.  Towards the Development of AgoKirs: New Pharmacological Activators to Study Kir2.x Channel and Target Cardiac Disease.

Authors:  Laura van der Schoor; Emma J van Hattum; Sophie M de Wilde; Netanja I Harlianto; Aart-Jan van Weert; Meye Bloothooft; Marcel A G van der Heyden
Journal:  Int J Mol Sci       Date:  2020-08-11       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.